Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1546604

	registered interest
	date	29/11/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Clinical Trials: Costs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether his Department has plans to legislate to make clinical trial costs public information.
	tabling member constituency	Newcastle upon Tyne Central
	tabling member printed	Chi Onwurah
	uin	98763
	answer	answer is ministerial correction date of answer 06/12/2022 answer text <p>There are no plans to do so.</p> answering member constituency Colchester answering member printed Will Quince question first answered 06/12/2022 10:11:51 answering member 4423 label Biography information for Will Quince previous answer version 39309 answering member constituency Colchester answering member printed Will Quince answering member 4423 label Biography information for Will Quince
	tabling member	4124 label Biography information for Chi Onwurah

1581359

	registered interest
	date	26/01/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Clinical Trials: Costs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the average cost incurred by companies of running (a) phase one, (b) phase two and (c) phase three clinical trials in the UK.
	tabling member constituency	Newcastle upon Tyne Central
	tabling member printed	Chi Onwurah
	uin	133644
	answer	answer is ministerial correction date of answer 02/02/2023 answer text <p>The Department does not hold information on costs incurred by companies of running clinical trials in the United Kingdom.</p> answering member constituency Colchester answering member printed Will Quince question first answered 02/02/2023 15:26:38 answering member 4423 label Biography information for Will Quince previous answer version 51900 answering member constituency Colchester answering member printed Will Quince answering member 4423 label Biography information for Will Quince
	tabling member	4124 label Biography information for Chi Onwurah

1172530

	registered interest
	date	22/01/2020
	answering body	Department for Work and Pensions
	answering dept id	29
	answering dept short name	Work and Pensions
	answering dept sort name	Work and Pensions
	hansard heading	Food Poverty: Newcastle upon Tyne
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Work and Pensions, what steps he plans to take to tackle food poverty in Newcastle upon Tyne constituency.
	tabling member constituency	Newcastle upon Tyne Central
	tabling member printed	Chi Onwurah
	uin	6678
	answer	answer is ministerial correction date of answer 28/01/2020 answer text <p>The government is committed to delivering a sustainable long-term solution to poverty in all its forms and in all parts of the UK by building a strong economy and ensuring that the benefit system works with the tax system and the labour market to support employment and higher pay.</p><p>The evidence shows that full time work substantially reduces the risk of being in poverty. Universal Credit is designed to help people move into work faster, stay in work longer and spend more time looking to increase their earnings, provides more financial help with childcare costs and removes the 16-hour ‘cliff edge<strong>’</strong> for those who are working. To help families keep more of what they earn we have delivered another rise in the National Living Wage, increasing a full-time worker’s annual pay by over £2,750 since its introduction, and by nearly £3,700 with the recently announced rise from this April, with our tax changes making basic rate tax payers over £1,200 better off from April 2019, compared with 2010.</p><p>In order to develop a better understanding of the drivers of food insecurity and identify which groups are most at risk we have introduced a new set of food security questions in the Family Resources Survey questionnaire from April 2019 onwards. This will enable us in the future to monitor the prevalence and severity of household food insecurity across the UK and for specific groups.</p> answering member constituency Colchester answering member printed Will Quince grouped question UIN 7197 question first answered 28/01/2020 17:41:58 answering member 4423 label Biography information for Will Quince previous answer version 3147 answering member constituency Colchester answering member printed Will Quince answering member 4423 label Biography information for Will Quince
	tabling member	4124 label Biography information for Chi Onwurah

1552156

	registered interest
	date	15/12/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Medical Records: Data Protection
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what his Department's policy is on the sharing of personal health data with organisations outside the NHS (a) with and (b) without a person's permission.
	tabling member constituency	Newcastle upon Tyne Central
	tabling member printed	Chi Onwurah
	uin	111586
	answer	answer is ministerial correction date of answer 23/12/2022 answer text <p>The use of patient information must comply with data protection legislation and the common law duty of confidence, where appropriate. Personal health data can only be used for purposes beyond individual care and treatment in specific circumstances and there must be a legal basis for any disclosure.</p><p>Confidential patient information can only be shared for non-health purposes where an individual has provided consent, where there is an over-riding public interest, where the information is required by law, or where there is a legal gateway which sets aside the common law duty of confidence. Any disclosure of patient data held within NHS Digital must comply with section 261 of the Health and Social Care Act 2012. Applications for access to patient data held by NHS Digital is made to its Data Access Request Service.</p><p>The National Data Opt-Out introduced in 2018 allows patients, in specified circumstances, to opt-out of their information being used for research or planning purposes and has been mandatory since 31 July 2022.</p> answering member constituency Colchester answering member printed Will Quince question first answered 23/12/2022 14:59:22 answering member 4423 label Biography information for Will Quince previous answer version 43984 answering member constituency Colchester answering member printed Will Quince answering member 4423 label Biography information for Will Quince
	tabling member	4124 label Biography information for Chi Onwurah

1579651

	registered interest
	date	23/01/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Medical Records: Data Protection
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 23 December 2022 to Question 111586, on Medical Records: Data Protection, in which specific circumstances personal health data can be used for purposes beyond individual care and treatment; what is the legal basis for any such disclosure; and whether his Department informs the affected patients.
	tabling member constituency	Newcastle upon Tyne Central
	tabling member printed	Chi Onwurah
	uin	129802
	answer	answer is ministerial correction date of answer 31/01/2023 answer text <p>Health and care organisations must ensure there is a lawful basis for sharing confidential patient information from a person's medical records for purposes beyond their individual care and treatment. This will generally mean that the person has provided their consent; there is a statutory or other legal requirement to disclose information; or there is an overriding public interest justification.</p><p>When using personal data, health and care organisations must comply with UK General Data Protection Regulation (UKGDPR) requirements and are guided by the eight Caldicott principles which state that confidential patient information should only be used when it is lawful, necessary and there is a clear purpose for doing so.</p><p>There are a limited number of legal gateways that set aside the common law duty of confidentiality, such as the powers of NHS Digital under the Health and Social Care Act 2012 to require or request data- for example for purposes directed by the Secretary of State for Health and Social Care. In addition, where it can be demonstrated that it is impracticable to obtain patient consent or work with anonymised data, the Health Service (Control of Patient Information) Regulations 2002 permit personal information to be used for cancer registries, communicable diseases and other threats to public health and enable the approval of the use of confidential patient information for other ‘medical purpose’s such as research, clinical audit and service planning by the Health Research Authority (HRA), for research, or the Secretary of State, for other medical purposes. Before approving such applications, the HRA and Secretary of State must be advised by the Confidentiality Advisory Group, an independent body which considers all applications, balancing patient and public interest with appropriate use of confidential patient information without consent.</p><p>Both the UKGDPR and Caldicott principles include specific principles related to transparency and it is the responsibility of each health and care organisation to make a range of information materials readily available to patients and members of the public about what, why, how, when and where confidential patient information might be shared.</p> answering member constituency Colchester answering member printed Will Quince grouped question UIN 129803 question first answered 31/01/2023 16:25:16 answering member 4423 label Biography information for Will Quince previous answer version 50770 answering member constituency Colchester answering member printed Will Quince answering member 4423 label Biography information for Will Quince
	tabling member	4124 label Biography information for Chi Onwurah

1581363

	registered interest
	date	26/01/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Medicine: Research
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what the remit is of the National Institute for Health and Care Research for the commercialisation of early-stage clinical research.
	tabling member constituency	Newcastle upon Tyne Central
	tabling member printed	Chi Onwurah
	uin	133648
	answer	answer is ministerial correction date of answer 02/02/2023 answer text <p>The National Institute for Health and Care Research (NIHR) invests in research, clinical expertise, specialist facilities, workforce and support services across a range of clinical areas. All NIHR research infrastructure actively supports collaboration with the life sciences industry and supports the commercialisation of new research and related technologies to help grow new companies (including SMEs). The NIHR has a dedicated IP Unit that aims to develop the capacity of NIHR to enter into commercial research partnerships with relevant life science or healthcare organisations as well as providing support in the area of commercial processes, IP management and advice in order to maximise return on investment.</p> answering member constituency Colchester answering member printed Will Quince question first answered 02/02/2023 15:28:43 answering member 4423 label Biography information for Will Quince previous answer version 51902 answering member constituency Colchester answering member printed Will Quince answering member 4423 label Biography information for Will Quince
	tabling member	4124 label Biography information for Chi Onwurah

1581473

	registered interest
	date	27/01/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Databases
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 26 January 2023 to Question 129798 on Palantir: Contracts, how much was paid to Palentir for its Foundry platform in each of the years it was providing this service; and whether her Department plans to use this platform after June 2023.
	tabling member constituency	Newcastle upon Tyne Central
	tabling member printed	Chi Onwurah
	uin	133960
	answer	answer is ministerial correction date of answer 16/02/2023 answer text <p>Contract spend for the provision of Foundry core platform services to National Health Service organisations was £23.5 million from 12 December 2020 to 11 December 2022, and £11.5 million from December 2022 to June 2023.</p><p>NHS England is in the process of re-procuring the COVID-19 Data Platform, which is hosted on Foundry, and has recently launched an open tender for a Federated Data Platform and Associated Services. It is anticipated that a contract will be awarded to the successful supplier in Autumn 2023.</p><p>NHS England is undertaking a fair, open and transparent procurement process to re-procure this service. It is inevitable that some form of transition will be required regardless of the successful supplier and as such, it is likely that NHS England will be required to continue to contract with the incumbent supplier to manage this transition.</p> answering member constituency Colchester answering member printed Will Quince question first answered 16/02/2023 15:48:21 answering member 4423 label Biography information for Will Quince previous answer version 52253 answering member constituency Colchester answering member printed Will Quince answering member 4423 label Biography information for Will Quince
	tabling member	4124 label Biography information for Chi Onwurah

1605410

	registered interest
	date	20/03/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Life Sciences
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether his Department has published recent guidance for small and medium-sized enterprises in the life sciences sector on accessing NHS procurement contracts; and whether his Department is taking steps to ensure that competition between large and small organisations for NHS procurement contracts is fair.
	tabling member constituency	Newcastle upon Tyne Central
	tabling member printed	Chi Onwurah
	uin	169277
	answer	answer is ministerial correction date of answer 30/03/2023 answer text <p>Procurement within the National Health Service is conducted within the rules of the Government’s Public Contracts Regulations 2015, which stipulates that all suppliers are treated fairly and equally in the procurement process.</p><p> </p><p>Procurement Policy Notes (PPNs) also provide provisions to allow contracting authorities not to unfairly exclude small and medium-sized enterprises (SMEs). In November 2020, PPN 11/20 published Reserving Below Threshold Procurements, allowing contracting authorities to restrict certain threshold procurements for SMEs, which is available at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/publications/procurement-policy-note-1120-reserving-below-threshold-procurements" target="_blank">https://www.gov.uk/government/publications/procurement-policy-note-1120-reserving-below-threshold-procurements</a></p><p> </p><p>PPN 01/23 Requirements to Publish on Contracts Finder, published in January 2023, reminded contracting authorities to publish all contract opportunities on Contract Finder. For NHS trusts and Foundation trusts this is set at £30,000.</p><p> </p><p>SMEs are critical to the NHS Supply Chain, and the NHS is fully committed to supporting SMEs so they can supply to the NHS. NHS England is establishing a strategic supplier relationship programme to help build and enhance our relationship with NHS suppliers, including SMEs.</p> answering member constituency Colchester answering member printed Will Quince question first answered 30/03/2023 14:32:40 answering member 4423 label Biography information for Will Quince previous answer version 64766 answering member constituency Colchester answering member printed Will Quince answering member 4423 label Biography information for Will Quince
	tabling member	4124 label Biography information for Chi Onwurah

1652119

	registered interest
	date	11/07/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Plantir: Newcastle upon Tyne Hospitals NHS Foundation Trust
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, for what reason the Palantir Foundry pilot at Newcastle Hospitals NHS Foundation Trust has been paused; and whether there are (a) financial and (b) operational costs as a result of the pilot's pausing.
	tabling member constituency	Newcastle upon Tyne Central
	tabling member printed	Chi Onwurah
	uin	193403
	answer	answer is ministerial correction date of answer 20/07/2023 answer text <p>The implementation of Foundry products in Newcastle Hospitals NHS Foundation Trust is centred around two key solutions using the platform.</p><p>The first of these is the Improving Elective Care Coordination for Patients Programme (IECCP), which provides solutions designed to: validate waiting lists to ensure accuracy; enable clinicians to tell patients where they are on the waiting list and easily reprioritise them where required; and calculate the number of un-booked minutes in a theatre session and ‘suggest’ patients to fill gaps based on their priority, making theatre scheduling significantly more efficient. The rollout of IECCP at Newcastle Hospitals NHS Foundation Trust has been live since March 2023.</p><p>The second of these is the OPTICA solution deployed as part of the Dynamic Discharges programme of work, which is designed to: provide a blueprint to help the National Health Service manage the way patients are discharged, freeing up beds for those in most need; increase the timeliness of discharge for patients; and improve bed utilisation. Rollout of the OPTICA solution at Newcastle Hospitals NHS Foundation Trust is dependent on the implementation of the IECCP modules (which were completed in March 2023) and updates to the Trust’s Electronic Patient Record to enable electronic collection of discharge information.</p><p>Due to operational pressures, the Trust temporarily paused engagement of OPTICA. However, it is now in a position to recommence activity.</p><p> </p><p> </p><p>No costs have been incurred as a result of the pause in delivery because the OPTICA implementation resources originally allocated to the Trust were diverted to implement the solution in other trusts. However, the OPTICA Team is now scheduled to begin discussions with the Newcastle Hospitals NHS Foundation Trust to implement OPTICA as quickly as the Trust can accommodate.</p> answering member constituency Colchester answering member printed Will Quince question first answered 20/07/2023 16:11:05 answering member 4423 label Biography information for Will Quince previous answer version 88181 answering member constituency Colchester answering member printed Will Quince answering member 4423 label Biography information for Will Quince
	tabling member	4124 label Biography information for Chi Onwurah

1536554

	registered interest
	date	26/10/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Voluntary Scheme for Branded Medicines Pricing and Access
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what (a) meetings and (b) discussions he has with representatives of (i) pharmaceutical and (ii) life science companies on changes to the Voluntary Scheme for Branded Medicines Pricing and Access (VPAS); and what assessment he has made of the potential impact of changes to the VPAS rebate rate on foreign direct investment into UK life science R&D.
	tabling member constituency	Newcastle upon Tyne Central
	tabling member printed	Chi Onwurah
	uin	72255
	answer	answer is ministerial correction date of answer 03/11/2022 answer text <p>Ministerial meetings are published on GOV.UK at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/collections/ministerial-gifts-hospitality-overseas-travel-and-meetings#2022" target="_blank">https://www.gov.uk/government/collections/ministerial-gifts-hospitality-overseas-travel-and-meetings#2022</a></p><p> </p><p>No specific assessment of the potential impact of changes to the Voluntary Scheme for Branded Medicines Pricing and Access rebate rate has been made. Changes to payment percentages reflects the Scheme working as intended to adjust for increased sales of branded medicines to the National Health Service. This will result in payment percentages at the rates projected when the Scheme was agreed with industry.</p> answering member constituency Colchester answering member printed Will Quince question first answered 03/11/2022 18:15:17 answering member 4423 label Biography information for Will Quince previous answer version 29183 answering member constituency Colchester answering member printed Will Quince answering member 4423 label Biography information for Will Quince
	tabling member	4124 label Biography information for Chi Onwurah